Development and Validation of (Bio)Sensors for the Identification of Pathogens

Launched by UNIVERSITY OF BOLOGNA · Aug 7, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on developing and testing new, easy-to-use devices that can quickly and accurately identify various infectious diseases, including COVID-19, bacterial infections like Pseudomonas aeruginosa, and parasitic infections like Leishmania infantum. The goal is to create portable tests that can work in different settings, not just in advanced laboratories. This is especially important for places with limited resources, where simple and affordable testing can make a big difference in managing diseases that affect many people.

To participate in the trial, individuals must be at least 18 years old and provide informed consent. Participants may include those who have tested positive or negative for SARS-CoV2, Pseudomonas aeruginosa, or Leishmania infantum. There are no specific health conditions that would exclude someone from participating. If you join the study, you can expect to help researchers find out how well these new testing devices work in real-world situations, potentially leading to faster and more reliable diagnoses for infectious diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Obtaining informed consent
• • Age ≥ 18 years
• • Patients who meet one of the following conditions: SARS-CoV2 positive patients (group 1), SARS-CoV2 negative patients (group 2), P. aeruginosa positive patients (group 3), P. aeruginosa negative patients (group 4), L. infantum positive patients (group 5), L. infantum negative patients (group 6).
• Exclusion Criteria:
• • None